Global Ophthalmic Anti-infective Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
The Ophthalmic Anti-infective Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Ophthalmic Anti-infective Drug market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Ophthalmic Anti-infective Drug market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Hospital occupied for % of the Ophthalmic Anti-infective Drug global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Eyedrops segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Ophthalmic Anti-infective Drug include Alcon, AbbVie, Bausch Health, Santen Pharmaceutical and Lupin Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Ophthalmic Anti-infective Drug market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Ophthalmic Anti-infective Drug companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Ophthalmic Anti-infective Drug market based on the following parameters – headquarters, products portfolio, Ophthalmic Anti-infective Drug revenue and gross margin, recent developments.
Evaluation and forecast the Ophthalmic Anti-infective Drug market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Ophthalmic Anti-infective Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
Chapter 1, to describe Ophthalmic Anti-infective Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Ophthalmic Anti-infective Drug, with revenue, gross margin and global market share of Ophthalmic Anti-infective Drug from 2019 to 2022.
Chapter 3, the Ophthalmic Anti-infective Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Ophthalmic Anti-infective Drug market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Ophthalmic Anti-infective Drug research findings and conclusion, appendix and data source.
The Ophthalmic Anti-infective Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Ophthalmic Anti-infective Drug market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Ophthalmic Anti-infective Drug market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Hospital occupied for % of the Ophthalmic Anti-infective Drug global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Eyedrops segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Ophthalmic Anti-infective Drug include Alcon, AbbVie, Bausch Health, Santen Pharmaceutical and Lupin Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Ophthalmic Anti-infective Drug market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Ophthalmic Anti-infective Drug companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Ophthalmic Anti-infective Drug market based on the following parameters – headquarters, products portfolio, Ophthalmic Anti-infective Drug revenue and gross margin, recent developments.
Evaluation and forecast the Ophthalmic Anti-infective Drug market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Ophthalmic Anti-infective Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
- Eyedrops
- Gels
- Ointments
- Other
- Hospital
- Retail Pharmacy
- Others
- Alcon
- AbbVie
- Bausch Health
- Santen Pharmaceutical
- Lupin Pharmaceuticals
- Apotex
- Akorn
- Johnson & Johnson
- Thea pharmaceuticals
- URSAPHARM
- SIMILASAN
- Jianfeng Group
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Australia)
- South America (Brazil, Argentina, Colombia and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa and Rest of Middle East & Africa)
Chapter 1, to describe Ophthalmic Anti-infective Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Ophthalmic Anti-infective Drug, with revenue, gross margin and global market share of Ophthalmic Anti-infective Drug from 2019 to 2022.
Chapter 3, the Ophthalmic Anti-infective Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Ophthalmic Anti-infective Drug market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Ophthalmic Anti-infective Drug research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Ophthalmic Anti-infective Drug
1.2 Classification of Ophthalmic Anti-infective Drug by Type
1.2.1 Overview: Global Ophthalmic Anti-infective Drug Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Ophthalmic Anti-infective Drug Revenue Market Share by Type in 2021
1.2.3 Eyedrops
1.2.4 Gels
1.2.5 Ointments
1.2.6 Other
1.3 Global Ophthalmic Anti-infective Drug Market by Application
1.3.1 Overview: Global Ophthalmic Anti-infective Drug Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Ophthalmic Anti-infective Drug Market Size & Forecast
1.5 Global Ophthalmic Anti-infective Drug Market Size and Forecast by Region
1.5.1 Global Ophthalmic Anti-infective Drug Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Ophthalmic Anti-infective Drug Market Size by Region, (2017-2022)
1.5.3 North America Ophthalmic Anti-infective Drug Market Size and Prospect (2017-2028)
1.5.4 Europe Ophthalmic Anti-infective Drug Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Ophthalmic Anti-infective Drug Market Size and Prospect (2017-2028)
1.5.6 South America Ophthalmic Anti-infective Drug Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Ophthalmic Anti-infective Drug Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Ophthalmic Anti-infective Drug Market Drivers
1.6.2 Ophthalmic Anti-infective Drug Market Restraints
1.6.3 Ophthalmic Anti-infective Drug Trends Analysis
2 COMPANY PROFILES
2.1 Alcon
2.1.1 Alcon Details
2.1.2 Alcon Major Business
2.1.3 Alcon Ophthalmic Anti-infective Drug Product and Solutions
2.1.4 Alcon Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Alcon Recent Developments and Future Plans
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Ophthalmic Anti-infective Drug Product and Solutions
2.2.4 AbbVie Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 AbbVie Recent Developments and Future Plans
2.3 Bausch Health
2.3.1 Bausch Health Details
2.3.2 Bausch Health Major Business
2.3.3 Bausch Health Ophthalmic Anti-infective Drug Product and Solutions
2.3.4 Bausch Health Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Bausch Health Recent Developments and Future Plans
2.4 Santen Pharmaceutical
2.4.1 Santen Pharmaceutical Details
2.4.2 Santen Pharmaceutical Major Business
2.4.3 Santen Pharmaceutical Ophthalmic Anti-infective Drug Product and Solutions
2.4.4 Santen Pharmaceutical Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Santen Pharmaceutical Recent Developments and Future Plans
2.5 Lupin Pharmaceuticals
2.5.1 Lupin Pharmaceuticals Details
2.5.2 Lupin Pharmaceuticals Major Business
2.5.3 Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Product and Solutions
2.5.4 Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Lupin Pharmaceuticals Recent Developments and Future Plans
2.6 Apotex
2.6.1 Apotex Details
2.6.2 Apotex Major Business
2.6.3 Apotex Ophthalmic Anti-infective Drug Product and Solutions
2.6.4 Apotex Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Apotex Recent Developments and Future Plans
2.7 Akorn
2.7.1 Akorn Details
2.7.2 Akorn Major Business
2.7.3 Akorn Ophthalmic Anti-infective Drug Product and Solutions
2.7.4 Akorn Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Akorn Recent Developments and Future Plans
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Ophthalmic Anti-infective Drug Product and Solutions
2.8.4 Johnson & Johnson Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Johnson & Johnson Recent Developments and Future Plans
2.9 Thea pharmaceuticals
2.9.1 Thea pharmaceuticals Details
2.9.2 Thea pharmaceuticals Major Business
2.9.3 Thea pharmaceuticals Ophthalmic Anti-infective Drug Product and Solutions
2.9.4 Thea pharmaceuticals Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Thea pharmaceuticals Recent Developments and Future Plans
2.10 URSAPHARM
2.10.1 URSAPHARM Details
2.10.2 URSAPHARM Major Business
2.10.3 URSAPHARM Ophthalmic Anti-infective Drug Product and Solutions
2.10.4 URSAPHARM Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 URSAPHARM Recent Developments and Future Plans
2.11 SIMILASAN
2.11.1 SIMILASAN Details
2.11.2 SIMILASAN Major Business
2.11.3 SIMILASAN Ophthalmic Anti-infective Drug Product and Solutions
2.11.4 SIMILASAN Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 SIMILASAN Recent Developments and Future Plans
2.12 Jianfeng Group
2.12.1 Jianfeng Group Details
2.12.2 Jianfeng Group Major Business
2.12.3 Jianfeng Group Ophthalmic Anti-infective Drug Product and Solutions
2.12.4 Jianfeng Group Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Jianfeng Group Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Ophthalmic Anti-infective Drug Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Ophthalmic Anti-infective Drug Players Market Share in 2021
3.2.2 Top 10 Ophthalmic Anti-infective Drug Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Ophthalmic Anti-infective Drug Players Head Office, Products and Services Provided
3.4 Ophthalmic Anti-infective Drug Mergers & Acquisitions
3.5 Ophthalmic Anti-infective Drug New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Ophthalmic Anti-infective Drug Revenue and Market Share by Type (2017-2022)
4.2 Global Ophthalmic Anti-infective Drug Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Ophthalmic Anti-infective Drug Revenue Market Share by Application (2017-2022)
5.2 Global Ophthalmic Anti-infective Drug Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Ophthalmic Anti-infective Drug Revenue by Type (2017-2028)
6.2 North America Ophthalmic Anti-infective Drug Revenue by Application (2017-2028)
6.3 North America Ophthalmic Anti-infective Drug Market Size by Country
6.3.1 North America Ophthalmic Anti-infective Drug Revenue by Country (2017-2028)
6.3.2 United States Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
6.3.3 Canada Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
6.3.4 Mexico Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Ophthalmic Anti-infective Drug Revenue by Type (2017-2028)
7.2 Europe Ophthalmic Anti-infective Drug Revenue by Application (2017-2028)
7.3 Europe Ophthalmic Anti-infective Drug Market Size by Country
7.3.1 Europe Ophthalmic Anti-infective Drug Revenue by Country (2017-2028)
7.3.2 Germany Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
7.3.3 France Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
7.3.5 Russia Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
7.3.6 Italy Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Type (2017-2028)
8.2 Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Application (2017-2028)
8.3 Asia-Pacific Ophthalmic Anti-infective Drug Market Size by Region
8.3.1 Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Region (2017-2028)
8.3.2 China Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
8.3.3 Japan Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
8.3.4 South Korea Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
8.3.5 India Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
8.3.7 Australia Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Ophthalmic Anti-infective Drug Revenue by Type (2017-2028)
9.2 South America Ophthalmic Anti-infective Drug Revenue by Application (2017-2028)
9.3 South America Ophthalmic Anti-infective Drug Market Size by Country
9.3.1 South America Ophthalmic Anti-infective Drug Revenue by Country (2017-2028)
9.3.2 Brazil Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
9.3.3 Argentina Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Type (2017-2028)
10.2 Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Application (2017-2028)
10.3 Middle East & Africa Ophthalmic Anti-infective Drug Market Size by Country
10.3.1 Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Country (2017-2028)
10.3.2 Turkey Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
10.3.4 UAE Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Ophthalmic Anti-infective Drug
1.2 Classification of Ophthalmic Anti-infective Drug by Type
1.2.1 Overview: Global Ophthalmic Anti-infective Drug Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Ophthalmic Anti-infective Drug Revenue Market Share by Type in 2021
1.2.3 Eyedrops
1.2.4 Gels
1.2.5 Ointments
1.2.6 Other
1.3 Global Ophthalmic Anti-infective Drug Market by Application
1.3.1 Overview: Global Ophthalmic Anti-infective Drug Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Ophthalmic Anti-infective Drug Market Size & Forecast
1.5 Global Ophthalmic Anti-infective Drug Market Size and Forecast by Region
1.5.1 Global Ophthalmic Anti-infective Drug Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Ophthalmic Anti-infective Drug Market Size by Region, (2017-2022)
1.5.3 North America Ophthalmic Anti-infective Drug Market Size and Prospect (2017-2028)
1.5.4 Europe Ophthalmic Anti-infective Drug Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Ophthalmic Anti-infective Drug Market Size and Prospect (2017-2028)
1.5.6 South America Ophthalmic Anti-infective Drug Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Ophthalmic Anti-infective Drug Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Ophthalmic Anti-infective Drug Market Drivers
1.6.2 Ophthalmic Anti-infective Drug Market Restraints
1.6.3 Ophthalmic Anti-infective Drug Trends Analysis
2 COMPANY PROFILES
2.1 Alcon
2.1.1 Alcon Details
2.1.2 Alcon Major Business
2.1.3 Alcon Ophthalmic Anti-infective Drug Product and Solutions
2.1.4 Alcon Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Alcon Recent Developments and Future Plans
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Ophthalmic Anti-infective Drug Product and Solutions
2.2.4 AbbVie Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 AbbVie Recent Developments and Future Plans
2.3 Bausch Health
2.3.1 Bausch Health Details
2.3.2 Bausch Health Major Business
2.3.3 Bausch Health Ophthalmic Anti-infective Drug Product and Solutions
2.3.4 Bausch Health Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Bausch Health Recent Developments and Future Plans
2.4 Santen Pharmaceutical
2.4.1 Santen Pharmaceutical Details
2.4.2 Santen Pharmaceutical Major Business
2.4.3 Santen Pharmaceutical Ophthalmic Anti-infective Drug Product and Solutions
2.4.4 Santen Pharmaceutical Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Santen Pharmaceutical Recent Developments and Future Plans
2.5 Lupin Pharmaceuticals
2.5.1 Lupin Pharmaceuticals Details
2.5.2 Lupin Pharmaceuticals Major Business
2.5.3 Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Product and Solutions
2.5.4 Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Lupin Pharmaceuticals Recent Developments and Future Plans
2.6 Apotex
2.6.1 Apotex Details
2.6.2 Apotex Major Business
2.6.3 Apotex Ophthalmic Anti-infective Drug Product and Solutions
2.6.4 Apotex Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Apotex Recent Developments and Future Plans
2.7 Akorn
2.7.1 Akorn Details
2.7.2 Akorn Major Business
2.7.3 Akorn Ophthalmic Anti-infective Drug Product and Solutions
2.7.4 Akorn Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Akorn Recent Developments and Future Plans
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Ophthalmic Anti-infective Drug Product and Solutions
2.8.4 Johnson & Johnson Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Johnson & Johnson Recent Developments and Future Plans
2.9 Thea pharmaceuticals
2.9.1 Thea pharmaceuticals Details
2.9.2 Thea pharmaceuticals Major Business
2.9.3 Thea pharmaceuticals Ophthalmic Anti-infective Drug Product and Solutions
2.9.4 Thea pharmaceuticals Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Thea pharmaceuticals Recent Developments and Future Plans
2.10 URSAPHARM
2.10.1 URSAPHARM Details
2.10.2 URSAPHARM Major Business
2.10.3 URSAPHARM Ophthalmic Anti-infective Drug Product and Solutions
2.10.4 URSAPHARM Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 URSAPHARM Recent Developments and Future Plans
2.11 SIMILASAN
2.11.1 SIMILASAN Details
2.11.2 SIMILASAN Major Business
2.11.3 SIMILASAN Ophthalmic Anti-infective Drug Product and Solutions
2.11.4 SIMILASAN Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 SIMILASAN Recent Developments and Future Plans
2.12 Jianfeng Group
2.12.1 Jianfeng Group Details
2.12.2 Jianfeng Group Major Business
2.12.3 Jianfeng Group Ophthalmic Anti-infective Drug Product and Solutions
2.12.4 Jianfeng Group Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Jianfeng Group Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Ophthalmic Anti-infective Drug Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Ophthalmic Anti-infective Drug Players Market Share in 2021
3.2.2 Top 10 Ophthalmic Anti-infective Drug Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Ophthalmic Anti-infective Drug Players Head Office, Products and Services Provided
3.4 Ophthalmic Anti-infective Drug Mergers & Acquisitions
3.5 Ophthalmic Anti-infective Drug New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Ophthalmic Anti-infective Drug Revenue and Market Share by Type (2017-2022)
4.2 Global Ophthalmic Anti-infective Drug Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Ophthalmic Anti-infective Drug Revenue Market Share by Application (2017-2022)
5.2 Global Ophthalmic Anti-infective Drug Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Ophthalmic Anti-infective Drug Revenue by Type (2017-2028)
6.2 North America Ophthalmic Anti-infective Drug Revenue by Application (2017-2028)
6.3 North America Ophthalmic Anti-infective Drug Market Size by Country
6.3.1 North America Ophthalmic Anti-infective Drug Revenue by Country (2017-2028)
6.3.2 United States Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
6.3.3 Canada Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
6.3.4 Mexico Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Ophthalmic Anti-infective Drug Revenue by Type (2017-2028)
7.2 Europe Ophthalmic Anti-infective Drug Revenue by Application (2017-2028)
7.3 Europe Ophthalmic Anti-infective Drug Market Size by Country
7.3.1 Europe Ophthalmic Anti-infective Drug Revenue by Country (2017-2028)
7.3.2 Germany Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
7.3.3 France Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
7.3.5 Russia Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
7.3.6 Italy Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Type (2017-2028)
8.2 Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Application (2017-2028)
8.3 Asia-Pacific Ophthalmic Anti-infective Drug Market Size by Region
8.3.1 Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Region (2017-2028)
8.3.2 China Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
8.3.3 Japan Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
8.3.4 South Korea Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
8.3.5 India Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
8.3.7 Australia Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Ophthalmic Anti-infective Drug Revenue by Type (2017-2028)
9.2 South America Ophthalmic Anti-infective Drug Revenue by Application (2017-2028)
9.3 South America Ophthalmic Anti-infective Drug Market Size by Country
9.3.1 South America Ophthalmic Anti-infective Drug Revenue by Country (2017-2028)
9.3.2 Brazil Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
9.3.3 Argentina Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Type (2017-2028)
10.2 Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Application (2017-2028)
10.3 Middle East & Africa Ophthalmic Anti-infective Drug Market Size by Country
10.3.1 Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Country (2017-2028)
10.3.2 Turkey Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
10.3.4 UAE Ophthalmic Anti-infective Drug Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Ophthalmic Anti-infective Drug Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Ophthalmic Anti-infective Drug Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Ophthalmic Anti-infective Drug Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Ophthalmic Anti-infective Drug Revenue (USD Million) by Region (2017-2022)
Table 5. Global Ophthalmic Anti-infective Drug Revenue Market Share by Region (2023-2028)
Table 6. Alcon Corporate Information, Head Office, and Major Competitors
Table 7. Alcon Major Business
Table 8. Alcon Ophthalmic Anti-infective Drug Product and Solutions
Table 9. Alcon Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. AbbVie Corporate Information, Head Office, and Major Competitors
Table 11. AbbVie Major Business
Table 12. AbbVie Ophthalmic Anti-infective Drug Product and Solutions
Table 13. AbbVie Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Bausch Health Corporate Information, Head Office, and Major Competitors
Table 15. Bausch Health Major Business
Table 16. Bausch Health Ophthalmic Anti-infective Drug Product and Solutions
Table 17. Bausch Health Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Santen Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 19. Santen Pharmaceutical Major Business
Table 20. Santen Pharmaceutical Ophthalmic Anti-infective Drug Product and Solutions
Table 21. Santen Pharmaceutical Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Lupin Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Lupin Pharmaceuticals Major Business
Table 24. Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Product and Solutions
Table 25. Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Apotex Corporate Information, Head Office, and Major Competitors
Table 27. Apotex Major Business
Table 28. Apotex Ophthalmic Anti-infective Drug Product and Solutions
Table 29. Apotex Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Akorn Corporate Information, Head Office, and Major Competitors
Table 31. Akorn Major Business
Table 32. Akorn Ophthalmic Anti-infective Drug Product and Solutions
Table 33. Akorn Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 35. Johnson & Johnson Major Business
Table 36. Johnson & Johnson Ophthalmic Anti-infective Drug Product and Solutions
Table 37. Johnson & Johnson Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Thea pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Thea pharmaceuticals Major Business
Table 40. Thea pharmaceuticals Ophthalmic Anti-infective Drug Product and Solutions
Table 41. Thea pharmaceuticals Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. URSAPHARM Corporate Information, Head Office, and Major Competitors
Table 43. URSAPHARM Major Business
Table 44. URSAPHARM Ophthalmic Anti-infective Drug Product and Solutions
Table 45. URSAPHARM Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. SIMILASAN Corporate Information, Head Office, and Major Competitors
Table 47. SIMILASAN Major Business
Table 48. SIMILASAN Ophthalmic Anti-infective Drug Product and Solutions
Table 49. SIMILASAN Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Jianfeng Group Corporate Information, Head Office, and Major Competitors
Table 51. Jianfeng Group Major Business
Table 52. Jianfeng Group Ophthalmic Anti-infective Drug Product and Solutions
Table 53. Jianfeng Group Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Global Ophthalmic Anti-infective Drug Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 55. Global Ophthalmic Anti-infective Drug Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 56. Breakdown of Ophthalmic Anti-infective Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Ophthalmic Anti-infective Drug Players Head Office, Products and Services Provided
Table 58. Ophthalmic Anti-infective Drug Mergers & Acquisitions in the Past Five Years
Table 59. Ophthalmic Anti-infective Drug New Entrants and Expansion Plans
Table 60. Global Ophthalmic Anti-infective Drug Revenue (USD Million) by Type (2017-2022)
Table 61. Global Ophthalmic Anti-infective Drug Revenue Share by Type (2017-2022)
Table 62. Global Ophthalmic Anti-infective Drug Revenue Forecast by Type (2023-2028)
Table 63. Global Ophthalmic Anti-infective Drug Revenue by Application (2017-2022)
Table 64. Global Ophthalmic Anti-infective Drug Revenue Forecast by Application (2023-2028)
Table 65. North America Ophthalmic Anti-infective Drug Revenue by Type (2017-2022) & (USD Million)
Table 66. North America Ophthalmic Anti-infective Drug Revenue by Type (2023-2028) & (USD Million)
Table 67. North America Ophthalmic Anti-infective Drug Revenue by Application (2017-2022) & (USD Million)
Table 68. North America Ophthalmic Anti-infective Drug Revenue by Application (2023-2028) & (USD Million)
Table 69. North America Ophthalmic Anti-infective Drug Revenue by Country (2017-2022) & (USD Million)
Table 70. North America Ophthalmic Anti-infective Drug Revenue by Country (2023-2028) & (USD Million)
Table 71. Europe Ophthalmic Anti-infective Drug Revenue by Type (2017-2022) & (USD Million)
Table 72. Europe Ophthalmic Anti-infective Drug Revenue by Type (2023-2028) & (USD Million)
Table 73. Europe Ophthalmic Anti-infective Drug Revenue by Application (2017-2022) & (USD Million)
Table 74. Europe Ophthalmic Anti-infective Drug Revenue by Application (2023-2028) & (USD Million)
Table 75. Europe Ophthalmic Anti-infective Drug Revenue by Country (2017-2022) & (USD Million)
Table 76. Europe Ophthalmic Anti-infective Drug Revenue by Country (2023-2028) & (USD Million)
Table 77. Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Type (2017-2022) & (USD Million)
Table 78. Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Type (2023-2028) & (USD Million)
Table 79. Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Application (2017-2022) & (USD Million)
Table 80. Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Application (2023-2028) & (USD Million)
Table 81. Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Region (2017-2022) & (USD Million)
Table 82. Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Region (2023-2028) & (USD Million)
Table 83. South America Ophthalmic Anti-infective Drug Revenue by Type (2017-2022) & (USD Million)
Table 84. South America Ophthalmic Anti-infective Drug Revenue by Type (2023-2028) & (USD Million)
Table 85. South America Ophthalmic Anti-infective Drug Revenue by Application (2017-2022) & (USD Million)
Table 86. South America Ophthalmic Anti-infective Drug Revenue by Application (2023-2028) & (USD Million)
Table 87. South America Ophthalmic Anti-infective Drug Revenue by Country (2017-2022) & (USD Million)
Table 88. South America Ophthalmic Anti-infective Drug Revenue by Country (2023-2028) & (USD Million)
Table 89. Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Type (2017-2022) & (USD Million)
Table 90. Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Type (2023-2028) & (USD Million)
Table 91. Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Application (2017-2022) & (USD Million)
Table 92. Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Application (2023-2028) & (USD Million)
Table 93. Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Country (2017-2022) & (USD Million)
Table 94. Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Ophthalmic Anti-infective Drug Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Ophthalmic Anti-infective Drug Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Ophthalmic Anti-infective Drug Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Ophthalmic Anti-infective Drug Revenue (USD Million) by Region (2017-2022)
Table 5. Global Ophthalmic Anti-infective Drug Revenue Market Share by Region (2023-2028)
Table 6. Alcon Corporate Information, Head Office, and Major Competitors
Table 7. Alcon Major Business
Table 8. Alcon Ophthalmic Anti-infective Drug Product and Solutions
Table 9. Alcon Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. AbbVie Corporate Information, Head Office, and Major Competitors
Table 11. AbbVie Major Business
Table 12. AbbVie Ophthalmic Anti-infective Drug Product and Solutions
Table 13. AbbVie Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Bausch Health Corporate Information, Head Office, and Major Competitors
Table 15. Bausch Health Major Business
Table 16. Bausch Health Ophthalmic Anti-infective Drug Product and Solutions
Table 17. Bausch Health Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Santen Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 19. Santen Pharmaceutical Major Business
Table 20. Santen Pharmaceutical Ophthalmic Anti-infective Drug Product and Solutions
Table 21. Santen Pharmaceutical Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Lupin Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Lupin Pharmaceuticals Major Business
Table 24. Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Product and Solutions
Table 25. Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Apotex Corporate Information, Head Office, and Major Competitors
Table 27. Apotex Major Business
Table 28. Apotex Ophthalmic Anti-infective Drug Product and Solutions
Table 29. Apotex Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Akorn Corporate Information, Head Office, and Major Competitors
Table 31. Akorn Major Business
Table 32. Akorn Ophthalmic Anti-infective Drug Product and Solutions
Table 33. Akorn Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 35. Johnson & Johnson Major Business
Table 36. Johnson & Johnson Ophthalmic Anti-infective Drug Product and Solutions
Table 37. Johnson & Johnson Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Thea pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Thea pharmaceuticals Major Business
Table 40. Thea pharmaceuticals Ophthalmic Anti-infective Drug Product and Solutions
Table 41. Thea pharmaceuticals Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. URSAPHARM Corporate Information, Head Office, and Major Competitors
Table 43. URSAPHARM Major Business
Table 44. URSAPHARM Ophthalmic Anti-infective Drug Product and Solutions
Table 45. URSAPHARM Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. SIMILASAN Corporate Information, Head Office, and Major Competitors
Table 47. SIMILASAN Major Business
Table 48. SIMILASAN Ophthalmic Anti-infective Drug Product and Solutions
Table 49. SIMILASAN Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Jianfeng Group Corporate Information, Head Office, and Major Competitors
Table 51. Jianfeng Group Major Business
Table 52. Jianfeng Group Ophthalmic Anti-infective Drug Product and Solutions
Table 53. Jianfeng Group Ophthalmic Anti-infective Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Global Ophthalmic Anti-infective Drug Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 55. Global Ophthalmic Anti-infective Drug Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 56. Breakdown of Ophthalmic Anti-infective Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Ophthalmic Anti-infective Drug Players Head Office, Products and Services Provided
Table 58. Ophthalmic Anti-infective Drug Mergers & Acquisitions in the Past Five Years
Table 59. Ophthalmic Anti-infective Drug New Entrants and Expansion Plans
Table 60. Global Ophthalmic Anti-infective Drug Revenue (USD Million) by Type (2017-2022)
Table 61. Global Ophthalmic Anti-infective Drug Revenue Share by Type (2017-2022)
Table 62. Global Ophthalmic Anti-infective Drug Revenue Forecast by Type (2023-2028)
Table 63. Global Ophthalmic Anti-infective Drug Revenue by Application (2017-2022)
Table 64. Global Ophthalmic Anti-infective Drug Revenue Forecast by Application (2023-2028)
Table 65. North America Ophthalmic Anti-infective Drug Revenue by Type (2017-2022) & (USD Million)
Table 66. North America Ophthalmic Anti-infective Drug Revenue by Type (2023-2028) & (USD Million)
Table 67. North America Ophthalmic Anti-infective Drug Revenue by Application (2017-2022) & (USD Million)
Table 68. North America Ophthalmic Anti-infective Drug Revenue by Application (2023-2028) & (USD Million)
Table 69. North America Ophthalmic Anti-infective Drug Revenue by Country (2017-2022) & (USD Million)
Table 70. North America Ophthalmic Anti-infective Drug Revenue by Country (2023-2028) & (USD Million)
Table 71. Europe Ophthalmic Anti-infective Drug Revenue by Type (2017-2022) & (USD Million)
Table 72. Europe Ophthalmic Anti-infective Drug Revenue by Type (2023-2028) & (USD Million)
Table 73. Europe Ophthalmic Anti-infective Drug Revenue by Application (2017-2022) & (USD Million)
Table 74. Europe Ophthalmic Anti-infective Drug Revenue by Application (2023-2028) & (USD Million)
Table 75. Europe Ophthalmic Anti-infective Drug Revenue by Country (2017-2022) & (USD Million)
Table 76. Europe Ophthalmic Anti-infective Drug Revenue by Country (2023-2028) & (USD Million)
Table 77. Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Type (2017-2022) & (USD Million)
Table 78. Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Type (2023-2028) & (USD Million)
Table 79. Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Application (2017-2022) & (USD Million)
Table 80. Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Application (2023-2028) & (USD Million)
Table 81. Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Region (2017-2022) & (USD Million)
Table 82. Asia-Pacific Ophthalmic Anti-infective Drug Revenue by Region (2023-2028) & (USD Million)
Table 83. South America Ophthalmic Anti-infective Drug Revenue by Type (2017-2022) & (USD Million)
Table 84. South America Ophthalmic Anti-infective Drug Revenue by Type (2023-2028) & (USD Million)
Table 85. South America Ophthalmic Anti-infective Drug Revenue by Application (2017-2022) & (USD Million)
Table 86. South America Ophthalmic Anti-infective Drug Revenue by Application (2023-2028) & (USD Million)
Table 87. South America Ophthalmic Anti-infective Drug Revenue by Country (2017-2022) & (USD Million)
Table 88. South America Ophthalmic Anti-infective Drug Revenue by Country (2023-2028) & (USD Million)
Table 89. Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Type (2017-2022) & (USD Million)
Table 90. Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Type (2023-2028) & (USD Million)
Table 91. Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Application (2017-2022) & (USD Million)
Table 92. Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Application (2023-2028) & (USD Million)
Table 93. Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Country (2017-2022) & (USD Million)
Table 94. Middle East & Africa Ophthalmic Anti-infective Drug Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Ophthalmic Anti-infective Drug Picture
Figure 2. Global Ophthalmic Anti-infective Drug Revenue Market Share by Type in 2021
Figure 3. Eyedrops
Figure 4. Gels
Figure 5. Ointments
Figure 6. Other
Figure 7. Ophthalmic Anti-infective Drug Revenue Market Share by Application in 2021
Figure 8. Hospital Picture
Figure 9. Retail Pharmacy Picture
Figure 10. Others Picture
Figure 11. Global Ophthalmic Anti-infective Drug Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Ophthalmic Anti-infective Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Ophthalmic Anti-infective Drug Revenue Market Share by Region (2017-2028)
Figure 14. Global Ophthalmic Anti-infective Drug Revenue Market Share by Region in 2021
Figure 15. North America Ophthalmic Anti-infective Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Ophthalmic Anti-infective Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Ophthalmic Anti-infective Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Ophthalmic Anti-infective Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Ophthalmic Anti-infective Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Ophthalmic Anti-infective Drug Market Drivers
Figure 21. Ophthalmic Anti-infective Drug Market Restraints
Figure 22. Ophthalmic Anti-infective Drug Market Trends
Figure 23. Alcon Recent Developments and Future Plans
Figure 24. AbbVie Recent Developments and Future Plans
Figure 25. Bausch Health Recent Developments and Future Plans
Figure 26. Santen Pharmaceutical Recent Developments and Future Plans
Figure 27. Lupin Pharmaceuticals Recent Developments and Future Plans
Figure 28. Apotex Recent Developments and Future Plans
Figure 29. Akorn Recent Developments and Future Plans
Figure 30. Johnson & Johnson Recent Developments and Future Plans
Figure 31. Thea pharmaceuticals Recent Developments and Future Plans
Figure 32. URSAPHARM Recent Developments and Future Plans
Figure 33. SIMILASAN Recent Developments and Future Plans
Figure 34. Jianfeng Group Recent Developments and Future Plans
Figure 35. Global Ophthalmic Anti-infective Drug Revenue Share by Players in 2021
Figure 36. Ophthalmic Anti-infective Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Ophthalmic Anti-infective Drug Revenue Market Share in 2021
Figure 38. Global Top 10 Players Ophthalmic Anti-infective Drug Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Ophthalmic Anti-infective Drug Revenue Share by Type in 2021
Figure 41. Global Ophthalmic Anti-infective Drug Market Share Forecast by Type (2023-2028)
Figure 42. Global Ophthalmic Anti-infective Drug Revenue Share by Application in 2021
Figure 43. Global Ophthalmic Anti-infective Drug Market Share Forecast by Application (2023-2028)
Figure 44. North America Ophthalmic Anti-infective Drug Sales Market Share by Type (2017-2028)
Figure 45. North America Ophthalmic Anti-infective Drug Sales Market Share by Application (2017-2028)
Figure 46. North America Ophthalmic Anti-infective Drug Revenue Market Share by Country (2017-2028)
Figure 47. United States Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Ophthalmic Anti-infective Drug Sales Market Share by Type (2017-2028)
Figure 51. Europe Ophthalmic Anti-infective Drug Sales Market Share by Application (2017-2028)
Figure 52. Europe Ophthalmic Anti-infective Drug Revenue Market Share by Country (2017-2028)
Figure 53. Germany Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Ophthalmic Anti-infective Drug Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Ophthalmic Anti-infective Drug Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Ophthalmic Anti-infective Drug Revenue Market Share by Region (2017-2028)
Figure 61. China Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Ophthalmic Anti-infective Drug Sales Market Share by Type (2017-2028)
Figure 68. South America Ophthalmic Anti-infective Drug Sales Market Share by Application (2017-2028)
Figure 69. South America Ophthalmic Anti-infective Drug Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Ophthalmic Anti-infective Drug Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Ophthalmic Anti-infective Drug Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Ophthalmic Anti-infective Drug Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
Figure 1. Ophthalmic Anti-infective Drug Picture
Figure 2. Global Ophthalmic Anti-infective Drug Revenue Market Share by Type in 2021
Figure 3. Eyedrops
Figure 4. Gels
Figure 5. Ointments
Figure 6. Other
Figure 7. Ophthalmic Anti-infective Drug Revenue Market Share by Application in 2021
Figure 8. Hospital Picture
Figure 9. Retail Pharmacy Picture
Figure 10. Others Picture
Figure 11. Global Ophthalmic Anti-infective Drug Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Ophthalmic Anti-infective Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Ophthalmic Anti-infective Drug Revenue Market Share by Region (2017-2028)
Figure 14. Global Ophthalmic Anti-infective Drug Revenue Market Share by Region in 2021
Figure 15. North America Ophthalmic Anti-infective Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Ophthalmic Anti-infective Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Ophthalmic Anti-infective Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Ophthalmic Anti-infective Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Ophthalmic Anti-infective Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Ophthalmic Anti-infective Drug Market Drivers
Figure 21. Ophthalmic Anti-infective Drug Market Restraints
Figure 22. Ophthalmic Anti-infective Drug Market Trends
Figure 23. Alcon Recent Developments and Future Plans
Figure 24. AbbVie Recent Developments and Future Plans
Figure 25. Bausch Health Recent Developments and Future Plans
Figure 26. Santen Pharmaceutical Recent Developments and Future Plans
Figure 27. Lupin Pharmaceuticals Recent Developments and Future Plans
Figure 28. Apotex Recent Developments and Future Plans
Figure 29. Akorn Recent Developments and Future Plans
Figure 30. Johnson & Johnson Recent Developments and Future Plans
Figure 31. Thea pharmaceuticals Recent Developments and Future Plans
Figure 32. URSAPHARM Recent Developments and Future Plans
Figure 33. SIMILASAN Recent Developments and Future Plans
Figure 34. Jianfeng Group Recent Developments and Future Plans
Figure 35. Global Ophthalmic Anti-infective Drug Revenue Share by Players in 2021
Figure 36. Ophthalmic Anti-infective Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Ophthalmic Anti-infective Drug Revenue Market Share in 2021
Figure 38. Global Top 10 Players Ophthalmic Anti-infective Drug Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Ophthalmic Anti-infective Drug Revenue Share by Type in 2021
Figure 41. Global Ophthalmic Anti-infective Drug Market Share Forecast by Type (2023-2028)
Figure 42. Global Ophthalmic Anti-infective Drug Revenue Share by Application in 2021
Figure 43. Global Ophthalmic Anti-infective Drug Market Share Forecast by Application (2023-2028)
Figure 44. North America Ophthalmic Anti-infective Drug Sales Market Share by Type (2017-2028)
Figure 45. North America Ophthalmic Anti-infective Drug Sales Market Share by Application (2017-2028)
Figure 46. North America Ophthalmic Anti-infective Drug Revenue Market Share by Country (2017-2028)
Figure 47. United States Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Ophthalmic Anti-infective Drug Sales Market Share by Type (2017-2028)
Figure 51. Europe Ophthalmic Anti-infective Drug Sales Market Share by Application (2017-2028)
Figure 52. Europe Ophthalmic Anti-infective Drug Revenue Market Share by Country (2017-2028)
Figure 53. Germany Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Ophthalmic Anti-infective Drug Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Ophthalmic Anti-infective Drug Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Ophthalmic Anti-infective Drug Revenue Market Share by Region (2017-2028)
Figure 61. China Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Ophthalmic Anti-infective Drug Sales Market Share by Type (2017-2028)
Figure 68. South America Ophthalmic Anti-infective Drug Sales Market Share by Application (2017-2028)
Figure 69. South America Ophthalmic Anti-infective Drug Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Ophthalmic Anti-infective Drug Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Ophthalmic Anti-infective Drug Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Ophthalmic Anti-infective Drug Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Ophthalmic Anti-infective Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
